Clinical Trials in Houston

Showing 11221-11240 of 15,366 trials

Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

NCT00003452

Current therapies for Stage IV bladder cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV bladder cancer PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV bladder cancer.

Stage IV Bladder Cancer

Burzynski Research Institute4 participantsStarted May 1996

Houston, Texas, United States

COMPLETED< 1 mile

Physiologic Definition of Bronchopulmonary Dysplasia

NCT01223287

This observational study was conducted to design and test a physiologic definition for bronchopulmonary dysplasia at 36 weeks of life. Infants were studied in a supine position with the pulse oximeter in position with good signal prior to collecting baseline data. Feedings and medications were given 30 minutes before the evaluation. Baseline data was collected on infant's current oxygen. Then, the infants were weaned to room air for 30 minutes. If saturations remain ≥90%, the infant was considered to have passed the oxygen reduction challenge (to NOT have BPD). The infant should then be placed back in his/her baseline oxygen. If the infant has saturations \<90% for 5 continuous minutes or \<80% for 15 seconds, the infant should be immediately placed back in his/her baseline oxygen, and the infant was considered to have NOT passed the challenge (to have BPD).

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more

NICHD Neonatal Research Network410 participantsStarted May 2005

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +18 more locations

Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Physiologic Definition of Bronchopulmonary Dysplasia

Find Trials by Condition in Houston

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Oral Rivaroxaban in Children With Venous Thrombosis

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer